Kaiser Permanente Vaccine Study Center, Oakland, California.
Institute for Health Research, Kaiser Permanente Colorado, Denver.
JAMA Pediatr. 2018 May 1;172(5):469-475. doi: 10.1001/jamapediatrics.2018.0082.
In recent years, rates of vaccination have been declining. Whether this phenomenon disproportionately affects children with autism spectrum disorder (ASD) or their younger siblings is unknown.
To investigate if children after receiving an ASD diagnosis obtain their remaining scheduled vaccines according to the Advisory Committee on Immunization Practices (ACIP) recommendations and to compare the vaccination patterns of younger siblings of children with ASD with the vaccination patterns of younger siblings of children without ASD.
DESIGN, SETTING, AND PARTICIPANTS: This investigation was a retrospective matched cohort study. The setting was 6 integrated health care delivery systems across the United States within the Vaccine Safety Datalink. Participants were children born between January 1, 1995, and September 30, 2010, and their younger siblings born between January 1, 1997, and September 30, 2014. The end of follow-up was September 30, 2015.
Recommended childhood vaccines between ages 1 month and 12 years.
The proportion of children who received all of their vaccine doses according to ACIP recommendations.
The study included 3729 children with ASD (676 [18.1%] female), 592 907 children without ASD, and their respective younger siblings. Among children without ASD, 250 193 (42.2%) were female. For vaccines recommended between ages 4 and 6 years, children with ASD were significantly less likely to be fully vaccinated compared with children without ASD (adjusted rate ratio, 0.87; 95% CI, 0.85-0.88). Within each age category, vaccination rates were significantly lower among younger siblings of children with ASD compared with younger siblings of children without ASD. The adjusted rate ratios varied from 0.86 for siblings younger than 1 year to 0.96 for those 11 to 12 years old. Parents who had a child with ASD were more likely to refuse at least 1 recommended vaccine for that child's younger sibling and to limit the number of vaccines administered during the younger sibling's first year of life.
Children with ASD and their younger siblings were undervaccinated compared with the general population. The results of this study suggest that children with ASD and their younger siblings are at increased risk of vaccine-preventable diseases.
近年来,疫苗接种率一直在下降。这种现象是否不成比例地影响自闭症谱系障碍(ASD)儿童或其年幼的兄弟姐妹尚不清楚。
调查接受 ASD 诊断后的儿童是否按照免疫实践咨询委员会(ACIP)的建议接种了剩余的计划疫苗,并比较 ASD 儿童的年幼兄弟姐妹与无 ASD 儿童的年幼兄弟姐妹的疫苗接种模式。
设计、地点和参与者:这是一项回顾性匹配队列研究。该研究地点为美国 6 个综合医疗保健系统,属于疫苗安全数据链接。参与者为 1995 年 1 月 1 日至 10 月 30 日之间出生的儿童及其 1997 年 1 月 1 日至 2014 年 10 月 30 日之间出生的年幼兄弟姐妹。随访结束日期为 2015 年 9 月 30 日。
1 个月至 12 岁儿童推荐的儿童疫苗。
根据 ACIP 建议接受所有疫苗剂量的儿童比例。
该研究包括 3729 名 ASD 儿童(676 [18.1%] 为女性)、592907 名无 ASD 儿童及其各自的年幼兄弟姐妹。在无 ASD 的儿童中,250193 名(42.2%)为女性。对于推荐在 4 至 6 岁之间接种的疫苗,与无 ASD 的儿童相比,ASD 儿童完全接种疫苗的可能性显著降低(调整后的比率比,0.87;95%CI,0.85-0.88)。在每个年龄组中,ASD 儿童的年幼兄弟姐妹的疫苗接种率明显低于无 ASD 儿童的年幼兄弟姐妹。调整后的比率比从 1 岁以下的兄弟姐妹的 0.86 到 11 至 12 岁的兄弟姐妹的 0.96 不等。有 ASD 儿童的父母更有可能拒绝为该儿童的年幼兄弟姐妹接种至少 1 种推荐疫苗,并限制该年幼兄弟姐妹在其生命的第一年接受疫苗的数量。
与一般人群相比,ASD 儿童及其年幼的兄弟姐妹疫苗接种不足。这项研究的结果表明,ASD 儿童及其年幼的兄弟姐妹患疫苗可预防疾病的风险增加。